Skip to main content
Equibles
PHIO logo

PHIO · Phio Pharmaceuticals Corp.

Track PHIO — free

Use PHIO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.13 +0.01 (+0.89%) At close · Aug 28
Rebalance outlook locked
Going-concern doubt — cleared Aug 6, 2026

The latest filing states the doubt was alleviated.

“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 6, 2026
Market Cap
$13.13M
Shares
11.62M

Phio Pharmaceuticals Corp. Earnings Call Transcripts

Quarterly earnings calls for Phio Pharmaceuticals Corp. (PHIO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Key facts CIK 1533040 CUSIP 71880W501 13F (30d) 20 filings 20 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)